Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Summary
SII systems are engineered with advanced optics, patented illumination, -90o C air-cooled high sensitivity cameras, absolute calibration for quantifiable imaging, excellent flexibility and ease of use. “Spectral Instruments Imaging systems perfectly complement the Bruker Preclinical offering,” said Keith Copeland, the CEO of SII. Their advanced BLI, FLI and X-ray imaging systems complement our portfolio to better serve the diverse needs of our preclinical customers. We are committed to fostering strong collaborations with our customers for advanced preclinical in vivo disease research.” Financial details of the transaction were not disclosed. Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.
Classifications
AskAI Classifications
LabelsLinked Companies
